vTv Therapeutics names biotechnology industry veteran Steven Tuch as CFO

Month after appointing a new CEO, High Point biopharmaceutical company vTv Therapeutics named Steven Tuch as CFO. Tuch joins the company as it looks to get back on track following several leadership changes.

REAL gastropub returns with a new location at Keauhou Lane

Huntington increases Columbus market dominance, widens gap with Chase

Developers detail plans for first office building in 116-acre Northline project

Cincinnati Children’s inks acquisition south of Dayton as it expands primary care reach

CMT Awards to move to Austin in 2023, after decades in Nashville

$669M solar farm plan rejected for Chapter 313 incentives in Bastrop County after neighbors express environmental concern

CRE Property Management Firms in the Austin area

Sweetgreen will start accepting cash again

vTv Therapeutics names biotechnology industry veteran Steven Tuch as CFO

Previous Operating in darkness: Ukrainian doctors learn tricks of the trade at Vanderbilt

Next UPMC to raise its starting wage to $18 an hour

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

St. Louis law firm adds a practice, and it’s hiring

PTM Partners ready to ‘embrace’ Live Local Act in St. Pete

Largest Homebuilders in Greater Baltimore

Daily Digest: SEC drops charges against Ripple execs; Value of S.F. office building plummets by over 80%

Service Corporation International, Carriage Services report mixed third-quarter earnings results

Targeting summer 2025, Corner Lot breaks ground on Southbank’s Artea project

MENU

FirstStar Group

More Stories

Federated Investors names director of responsible investing